Scientific Programme

DAY 1 (July 14th Friday 2017)

8:00 – 9:00 am: BREAKFAST AND REGISTRATION

Session 1: Medical Oncology issues

Speakers: Dr.AdamBrufsky, Univ of Pittsburgh; Dr. Prakash Vishnu, Mayo Clinic; Dr ShekarPatil,    H C G , Bangalore.

9:00-9:30am: HER2 therapy in neo-adjuvant and metastatic setting

9:30- 10:00am: Indian breast cancer scenario – an Oncologist’s perspective

10:00- 10.10am: Q & A session

10:10- 10.30am: INAUGURAL CEREMONY & Tea Break

Session 2: Prognostic /Predictive markers in breast cancer

Role of new genomic testing in breast cancer

Speaker: Dr.Joseph Anderson,  Genomic Health Inc, CA

10:30- 11:00am: Breast cancer prognostic factors: NCCN clinical practice guidelines

11:00- 11:20am: Staging: 8th edition AJCC staging manual; moving from anatomy to biology

11:20-11:30am: Q & A session and Comments by Drs.Brufsky, Vishnu and Patil

Session 3: Neo-adjuvant therapy changes; Radiation Oncologist perspective

Speaker: Dr.Al Taira, Sutter health, CA

11:30 – 12:00pm: Post- mastectomy radiation in small tumors: guidelines implications

12:00-12:10pm: Q & A session

Session 4: 12:10pm- 1:10pm: Case based discussions

ER/PR in breast cancer, reporting and CAP/ASCO guideline and HER2 testing issues

Speakers: Dr.Mamatha Chivukula, Sutter Health; Dr Rekha V Kumar, KMIO, Bangalore and Dr Aziza Nassar, Mayo Clinic

1:10pm- 2:00pm: Lunch

Session 5: Immunotherapy in breast cancer

2:00- 2:40pm: Triple negative breast cancers Biology and prevalence

Dr ShekarPatil, Dr.AdamBrufsky

2:40 -3:20pm: Role of Immunotherapy in breast cancer and introduction to new biomarkers PDL1

Speakers: Dr.MamathaChivukula and Dr.Prakash Vishnu.

3:20- 3:40pm: Q & A session

3:40 -4:00pm: Tea Break

4:00 -5:00pm: Paper & Poster presentation

7:00pm Onwards- Banquet.

 

 

 

 

 

Day 2 (July 15th, Saturday, 2017)

8:00 – 8:30 am: BREAKFAST

8:30 – 9:00 am: Career development forum for Medical students/pathologists –in-training – Dr.BruceSmoller. 

Session 6: Proliferative lesions and related precursor lesions and molecular aspects

Speakers: Dr.AzizaNassar, Dr.Reena Bharadwaj,  Department of Pathology, AFMC, Pune,  Dr. MamathaChivukula and Dr.Sertac Kip, Geisinger Health

9:00– 9:20 am: Proliferative lesions

9:20- 9:50am: Flat epithelial atypia (FEA) and Atypical ductal epithelial hyperplasia (ADH) –seeking second opinion

9:50- 10:20am: Lobular neoplasia

10:20- 10:40 am: Molecular aspects of ductal and lobular in-situ lesions

10:40 – 11:00: Tea Break

Session 7: DCIS management from radiation and medical Oncologist’s perspective

11:00 am- 11:40 am: Speakers: Dr.AlTaira, and Dr.Prakash Vishnu,

11:40 11:50 am: Q&A session

Session 8: Clinical and Radiologic issues across the countries

Speakers: Dr. Jyotsna Rao ,Apollo, Hyderabad.

11:50– 12:20pm: Radiology and pathologic discordant issues

12: 20-12:30pm: Q & A session

12:30pm- 1:30pm: Lunch break

Session 9: Molecular aspects of In-situ lesions

Moderator: Aziza Nassar.

Speakers: Dr.Joseph Anderson and Dr.Sertac Kip.

1:30-1:50pm: The DCIS Score: a molecular prognostic assay

1:50 – 2:00pm: Comments by Dr.Sertac kip.

2:00- 2:10pm: Q & A session

Session 10: Role of Immunohistochemistry (IHC) in breast pathology (Case based session)

Speaker: Dr.AzizaNassar, Dr.BruceSmoller

2:10-3:00pm: Diagnostic issues of Immunohistochemistry (IHC)

3:00 pm – 3:10pm: Q & A session

3:10pm-3:20pm: Break

Session 11: genetic and Molecular aspects of breast cancer

Speakers: Dr.Sertac Kip; Dr Aarthi Ravichandran, Senior scientist III, Strand life sciences, Bangalore.

3:20- 3:40pm: Role of Next-generation testing (NGS) in Breast cancer how far we have come?

3:50- 4:10pm: Next Generation Sequencing (NGS) & Personalised Medicine in Oncology.

4:10 pm – 4:20pm: Q & A session

4:30 pm: Final thoughts Dr.MamathaChivukula  and Dr Dayananda Biligi.

 

Kindly note-Delegates can submit abstract  for poster presentations in any topic concerned to Pathology ,but the paper presentation is restricted only to Breast pathology.